Do some comparisons on Elite Pharma and Delex Pharma.
Elite Pharma:
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and distributes niche generic products. Elite's product lines consist of immediate-release and controlled-release, solid oral dose products, which are marketed under the Elite Laboratories label, as well as pursuant to licenses granted to third-party pharmaceutical marketing and distribution organizations.
OS: 1.1b
PPS: $0.70
Market Cap: $750m
2023 sales: $56m
PS ratio: 14
If Delex can do $40-$50m in 2024 sales and trade at just 10x sales in comparison you have a $500m company.
With the following post merger OS:
1b = $0.50 PPS
750m = $0.75 PPS
500m = $1 PPS
250m = $2 PPS
If the float is only 10m-30m post merger, as most will be restricted, these numbers will be too low.
Monster move coming as this all plays out.
Market Data 
Markets 
